These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17713691)

  • 1. [Treatment-resistant mood disorders].
    Machado-Vieira R; Soares JC
    Braz J Psychiatry; 2007 Oct; 29 Suppl 2():S48-54. PubMed ID: 17713691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.
    Manji HK; Quiroz JA; Sporn J; Payne JL; Denicoff K; A Gray N; Zarate CA; Charney DS
    Biol Psychiatry; 2003 Apr; 53(8):707-42. PubMed ID: 12706957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of mood disorders.
    Thase ME; Denko T
    Annu Rev Clin Psychol; 2008; 4():53-91. PubMed ID: 18370614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of depressive and bipolar disorder patients with mixed features.
    Tondo L; Vázquez GH; Pinna M; Vaccotto PA; Baldessarini RJ
    Acta Psychiatr Scand; 2018 Sep; 138(3):243-252. PubMed ID: 29862493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Drugs for Mood Disorders.
    Peedicayil J; Kumar A
    Prog Mol Biol Transl Sci; 2018; 157():151-174. PubMed ID: 29933949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic plasticity and mood disorders.
    Duman RS
    Mol Psychiatry; 2002; 7 Suppl 1():S29-34. PubMed ID: 11986993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
    Nierenberg AA; Ostacher MJ; Calabrese JR; Ketter TA; Marangell LB; Miklowitz DJ; Miyahara S; Bauer MS; Thase ME; Wisniewski SR; Sachs GS
    Am J Psychiatry; 2006 Feb; 163(2):210-6. PubMed ID: 16449473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multiaxial evaluation of the pathophysiology of mood disorder and therapeutic mechanisms of clinical drugs by neuronal plasticity and neuronal load].
    Omata N; Mizuno T; Mitsuya H; Wada Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Nov; 33(5-6):231-6. PubMed ID: 25069263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease.
    Cruess DG; Evans DL; Repetto MJ; Gettes D; Douglas SD; Petitto JM
    Biol Psychiatry; 2003 Aug; 54(3):307-16. PubMed ID: 12893106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology.
    Quiroz JA; Singh J; Gould TD; Denicoff KD; Zarate CA; Manji HK
    Mol Psychiatry; 2004 Aug; 9(8):756-76. PubMed ID: 15136795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The promise of ketamine for treatment-resistant depression: current evidence and future directions.
    DeWilde KE; Levitch CF; Murrough JW; Mathew SJ; Iosifescu DV
    Ann N Y Acad Sci; 2015 May; 1345(1):47-58. PubMed ID: 25649308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bipolar depression: management options.
    Malhi GS; Mitchell PB; Salim S
    CNS Drugs; 2003; 17(1):9-25. PubMed ID: 12467490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent cases of corticosteroid-induced mood disorder: clinical characteristics and treatment.
    Wada K; Yamada N; Suzuki H; Lee Y; Kuroda S
    J Clin Psychiatry; 2000 Apr; 61(4):261-7. PubMed ID: 10830146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.
    Yatham LN; Kennedy SH; O'Donovan C; Parikh SV; MacQueen G; McIntyre RS; Sharma V; Beaulieu S;
    Bipolar Disord; 2006 Dec; 8(6):721-39. PubMed ID: 17156158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed features in major depressive disorder: diagnoses and treatments.
    Suppes T; Ostacher M
    CNS Spectr; 2017 Apr; 22(2):155-160. PubMed ID: 28462772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012.
    Kanba S; Kato T; Terao T; Yamada K;
    Psychiatry Clin Neurosci; 2013 Jul; 67(5):285-300. PubMed ID: 23773266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of schizoaffective disorder and schizophrenia with mood symptoms.
    Levinson DF; Umapathy C; Musthaq M
    Am J Psychiatry; 1999 Aug; 156(8):1138-48. PubMed ID: 10450252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case series on the hypothesized connection between dementia and bipolar spectrum disorders: bipolar type VI?
    Ng B; Camacho A; Lara DR; Brunstein MG; Pinto OC; Akiskal HS
    J Affect Disord; 2008 Apr; 107(1-3):307-15. PubMed ID: 17889374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.